Reaction of 6,7‐bis(chloromethyl)‐1,2,3,4‐tetrahydronaphthalene with tellurium powder and potassium iodide in 2‐butoxyethanol gave 2,2‐diiodo‐1,3,5,6,7,8‐hexahydro‐naphtho[2,3‐c]tellurophene(1) as a red‐orange solid in 40% yield. Reduction of 1 with hydrazine hydrate gave a pale yellow solid of 1,3,5,6,7,8‐hexahydronaphtho[2,3‐c]telluro‐phene(2) in 80% yield. Chlorination, bromination of 2 and its reaction with benzyl bromide and N‐bromosuccinimide were reported. 2,2‐Bis(dimethyldithiocarbamato)‐, 2,2‐bis (diethyldithiocarbamato)‐ and 2,2‐bis(piperidine‐1‐carbodithioate)‐1,3,5,6,7,8‐hexahydro‐naphtho[2,3‐c]tellurophene were prepared by the reaction of the corresponding sodium dithiocarbamate salt with 1. Mononuclear platinum complex (ie, [(C12H14Te)2PtCl2]) was obtained by the reaction of 2 with K2PtCl4. Reaction of 6,7‐bis(chloromethyl)‐1,2,3,4‐tetrahydronaphthalene with KTeCN in DMSO solution gave 2,2‐dihydroxo‐1,3,5,6,7,8‐hexahydronaphtho[2,3‐c]tellurophene (11) as a white solid in 55% yield. All these new compounds were characterized by elemental analysis, IR, 1H, and 13C NMR, and mass spectroscopic data.
No takes yet. Share an insight, caveat, or question.
Al‐Rubaie et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: